Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $136.48 million. The enterprise value is $107.81 million.
| Market Cap | 136.48M |
| Enterprise Value | 107.81M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 103.40 million shares outstanding. The number of shares has increased by 92.40% in one year.
| Current Share Class | 103.40M |
| Shares Outstanding | 103.40M |
| Shares Change (YoY) | +92.40% |
| Shares Change (QoQ) | +18.11% |
| Owned by Insiders (%) | 0.38% |
| Owned by Institutions (%) | 31.75% |
| Float | 95.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 6.36 |
| PB Ratio | 24.30 |
| P/TBV Ratio | 30.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 1.83.
| Current Ratio | 1.00 |
| Quick Ratio | 0.92 |
| Debt / Equity | 1.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -409.87% and return on invested capital (ROIC) is -192.15%.
| Return on Equity (ROE) | -409.87% |
| Return on Assets (ROA) | -84.23% |
| Return on Invested Capital (ROIC) | -192.15% |
| Return on Capital Employed (ROCE) | -836.58% |
| Weighted Average Cost of Capital (WACC) | 11.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$602,027 |
| Employee Count | 112 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.08% in the last 52 weeks. The beta is 1.51, so INO's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -33.08% |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 1.45 |
| Relative Strength Index (RSI) | 67.39 |
| Average Volume (20 Days) | 6,957,126 |
Short Selling Information
The latest short interest is 16.04 million, so 15.52% of the outstanding shares have been sold short.
| Short Interest | 16.04M |
| Short Previous Month | 14.57M |
| Short % of Shares Out | 15.52% |
| Short % of Float | 16.75% |
| Short Ratio (days to cover) | 4.65 |
Income Statement
| Revenue | n/a |
| Gross Profit | -48.49M |
| Operating Income | -79.26M |
| Pretax Income | -67.43M |
| Net Income | -67.43M |
| EBITDA | -77.93M |
| EBIT | -79.26M |
| Earnings Per Share (EPS) | -$1.03 |
Balance Sheet
The company has $36.67 million in cash and $8.00 million in debt, with a net cash position of $28.67 million or $0.28 per share.
| Cash & Cash Equivalents | 36.67M |
| Total Debt | 8.00M |
| Net Cash | 28.67M |
| Net Cash Per Share | $0.28 |
| Equity (Book Value) | 4.37M |
| Book Value Per Share | 0.05 |
| Working Capital | -1,810 |
Cash Flow
In the last 12 months, operating cash flow was -$80.58 million and capital expenditures -$195,395, giving a free cash flow of -$80.78 million.
| Operating Cash Flow | -80.58M |
| Capital Expenditures | -195,395 |
| Depreciation & Amortization | 1.33M |
| Net Borrowing | n/a |
| Free Cash Flow | -80.78M |
| FCF Per Share | -$0.78 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -92.40% |
| Shareholder Yield | -92.40% |
| Earnings Yield | -50.55% |
| FCF Yield | -60.56% |
Analyst Forecast
The average price target for INO is $3.17, which is 140.15% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.17 |
| Price Target Difference | 140.15% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 965.76% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
INO has an Altman Z-Score of -56. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -56 |
| Piotroski F-Score | n/a |